Radek Lakomý

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Eric Van Cutsem, Josep Tabernero, Radek Lakomý et al. · Journal of Clinical Oncology · 2012 · 1.4K citations

Medicine, Oncology, Pharmacology +15

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

Martina Rédová, Alexandr Poprach, Jana Nekvindová et al. · Journal of Translational Medicine · 2012 · 278 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

Josep Tabernero, Eric Van Cutsem, Radek Lakomý et al. · European Journal of Cancer · 2013 · 238 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

MiR‐195, miR‐196b, miR‐181c, miR‐21 expression levels and <i>O</i>‐6‐methylguanine‐DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

Radek Lakomý, Jiří Šáňa, Simona Hankeová et al. · Cancer Science · 2011 · 156 citations · Full text

Medicine, Molecular Biology, Oncology +17

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients

Ondřej Slabý, Radek Lakomý, Pavel Fadrus et al. · Neoplasma · 2010 · 141 citations

Medicine, Molecular Biology, Oncology +17